Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roederer

Showing results (301-310 of 405) with videos related to

Pageof 41
Sort By:
Cell Systems|November 6, 2024
Markov field network model of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaquesShu Wang, Amy J Myers, Edward B Irvine, et al.
NPJ Vaccines|January 26, 2021
Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal centerLeila Eslamizar, Constantinos Petrovas, David J Leggat, et al.
Journal of Virology|February 16, 2018
Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph NodesSinthujan Jegaskanda, Rosemarie D Mason, Sarah F Andrews, et al.
Immunity|October 7, 2019
Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan ShieldsJason Gorman, Rosemarie D Mason, Leonard Nettey, et al.
The Journal of Clinical Investigation|August 28, 2012
CD4 T follicular helper cell dynamics during SIV infectionConstantinos Petrovas, Takuya Yamamoto, Michael Y Gerner, et al.
Plos Pathogens|June 16, 2022
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4Hugh C Welles, Hannah A D King, Leonard Nettey, et al.
Journal for Immunotherapy of Cancer|November 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumorsKevin Conlon, Dionysios C Watson, Thomas A Waldmann, et al.
Molecular Systems Biology|May 4, 2019
Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protectionSrivamshi Pittala, Kenneth Bagley, Jennifer A Schwartz, et al.
Science Immunology|March 10, 2022
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissuesChristine E Nelson, Sivaranjani Namasivayam, Taylor W Foreman, et al.
The Journal of Infectious Diseases|March 14, 2013
Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoireJoseph P Casazza, Kathryn A Bowman, Selorm Adzaku, et al.
Pageof 41

Showing results (301-310 of 405) with videos related to

Sort By:
Pageof 41
Cell Systems|November 6, 2024
Markov field network model of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaquesShu Wang, Amy J Myers, Edward B Irvine, et al.
NPJ Vaccines|January 26, 2021
Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal centerLeila Eslamizar, Constantinos Petrovas, David J Leggat, et al.
Journal of Virology|February 16, 2018
Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph NodesSinthujan Jegaskanda, Rosemarie D Mason, Sarah F Andrews, et al.
Immunity|October 7, 2019
Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan ShieldsJason Gorman, Rosemarie D Mason, Leonard Nettey, et al.
The Journal of Clinical Investigation|August 28, 2012
CD4 T follicular helper cell dynamics during SIV infectionConstantinos Petrovas, Takuya Yamamoto, Michael Y Gerner, et al.
Plos Pathogens|June 16, 2022
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4Hugh C Welles, Hannah A D King, Leonard Nettey, et al.
Journal for Immunotherapy of Cancer|November 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumorsKevin Conlon, Dionysios C Watson, Thomas A Waldmann, et al.
Molecular Systems Biology|May 4, 2019
Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protectionSrivamshi Pittala, Kenneth Bagley, Jennifer A Schwartz, et al.
Science Immunology|March 10, 2022
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissuesChristine E Nelson, Sivaranjani Namasivayam, Taylor W Foreman, et al.
The Journal of Infectious Diseases|March 14, 2013
Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoireJoseph P Casazza, Kathryn A Bowman, Selorm Adzaku, et al.
Pageof 41